UK’s CMA Reveals Details Of Fludrocortisone Probe
If the CMA concludes that there has been an infringement, Aspen has agreed to pay £2.1m.
The UK’s CMA has accused Tiofarma and Amilco of colluding with Aspen over an illegal agreement that resulted in significant price hikes for fludrocortisone.
